Insider · CIK 0001747528

Hughes Steven George

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001747528

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-18	RNAAtrium Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−21.5K sh	$8.95	−$192K	51,638
2026-04-20	RNAAtrium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+60K sh	—	—	60,000
2026-04-20	RNAAtrium Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+30K sh	—	—	73,097
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−50K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−73.3K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−68.5K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−116K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−49.3K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−74K sh	—	—	0
2026-01-21	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−2,878 sh	$72.45	−$209K	31,599
2026-01-21	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−2,017 sh	$72.45	−$146K	34,477
2026-01-07	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−2,373 sh	$72.23	−$171K	36,494
2025-10-22	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−2,209 sh	$47.54	−$105K	38,867
2025-10-22	RNAMAvidity Biosciences, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,209 sh	$10.16	+$22.4K	41,076
2025-10-22	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,209 sh	—	—	68,458
2025-09-22	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,208 sh	—	—	70,667
2025-09-22	RNAMAvidity Biosciences, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,208 sh	$10.16	+$22.4K	41,075
2025-09-22	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−2,208 sh	$40.58	−$89.6K	38,867
2025-09-15	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−1,542 sh	$45.41	−$70K	38,867
2025-09-15	RNAMAvidity Biosciences, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,542 sh	$6.57	+$10.1K	40,409
2025-09-15	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,542 sh	—	—	49,333
2025-08-22	RNAMAvidity Biosciences, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,208 sh	$10.16	+$22.4K	41,075
2025-08-22	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,208 sh	—	—	72,875
2025-08-22	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−2,208 sh	$46.40	−$102K	38,867
2025-08-13	RNAMAvidity Biosciences, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,542 sh	$6.57	+$10.1K	40,409
2025-08-13	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−1,542 sh	$46.66	−$71.9K	38,867
2025-08-13	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,542 sh	—	—	50,875
2025-08-06	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−17.7K sh	$42.74	−$755K	72,850
2025-08-06	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−34K sh	$42.74	−$1.45M	38,867
2025-08-06	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−11.3K sh	—	—	73,342
2025-08-06	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−12.3K sh	—	—	52,417
2025-08-06	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−6,167 sh	—	—	74,000
2025-08-06	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−17.7K sh	—	—	75,083
2025-08-06	RNAMAvidity Biosciences, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+11.3K sh	$15.96	+$180K	84,133
2025-08-06	RNAMAvidity Biosciences, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+12.3K sh	$6.57	+$81K	85,184
2025-08-06	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−11.3K sh	$42.74	−$482K	72,850
2025-08-06	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−12.3K sh	$42.74	−$527K	72,850
2025-08-06	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−6,167 sh	$42.74	−$264K	72,850
2025-08-06	RNAMAvidity Biosciences, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+17.7K sh	$10.16	+$179K	90,517
2025-08-06	RNAMAvidity Biosciences, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+6,167 sh	$22.47	+$139K	79,017
2025-03-20	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−9,578 sh	$31.06	−$297K	72,850
2025-01-21	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−2,032 sh	$28.59	−$58.1K	82,428
2025-01-21	RNAMAvidity Biosciences, Inc.S Sale	Chief Medical Officer	SSale	−1,915 sh	$28.60	−$54.8K	84,460
2025-01-06	RNAMAvidity Biosciences, Inc.A Award	Chief Medical Officer	AAward	+25K sh	—	—	86,375
2025-01-06	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+50K sh	—	—	50,000
2020-12-18	ARCTArcturus Therapeutics Holdings Inc. · Stock Option (right to buy)A Award	Chief Development Officer	AAward	+50K sh	—	—	50,000
2020-02-18	ARCTArcturus Therapeutics Holdings Inc. · Stock Option (right to buy)A Award	Chief Development Officer	AAward	+75K sh	—	—	75,000
2019-08-16	VIVSVivoSim Labs, INC.S Sale	Chief Medical Officer	SSale	−22.2K sh	$0.29	−$6,431.139	138,484
2018-08-14	VIVSVivoSim Labs, INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+975K sh	—	—	974,694
2018-08-14	VIVSVivoSim Labs, INC.A Award	Chief Medical Officer	AAward	+161K sh	—	—	160,714

Recent filings

Accepted (ET)
Sep 224
Hughes Steven George0001193125-26-397967
SEC(opens sec.gov)
Apr 224
Hughes Steven George0001193125-26-170963
SEC(opens sec.gov)
Feb 274
Hughes Steven George0001193125-26-082277
SEC(opens sec.gov)
Jan 234
Hughes Steven George0001599901-26-000026
SEC(opens sec.gov)
Jan 94
Hughes Steven George0001599901-26-000009
SEC(opens sec.gov)
Oct 244
Hughes Steven George0001599901-25-000200
SEC(opens sec.gov)
Sep 234
Hughes Steven George0001599901-25-000190
SEC(opens sec.gov)
Sep 174
Hughes Steven George0001599901-25-000186
SEC(opens sec.gov)

Companies

Address

C/O ATRIUM THERAPEUTICS, INC. 10578 SCIENCE CENTER DRIVE, SUITE 125

SAN DIEGO, CA, 92121